ArticleBioinformatics (Oxford, England)2026
SIMLINK enables accurate variant pathogenicity prediction through modeling the gene-variant-feature association structure.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationPredicting variant pathogenicity is crucial for clinical genetics. Existing approaches face two primary limitations. First, biologically, data for pathogenicity prediction often lacks explicit modeling of the gene-variant-feature association structure. A single gene can harbor multiple variants, and each variant can be characterized by multiple features intrinsically associated with its parent gene. Current methods fail to explicitly model the gene-variant-feature association, thus limiting their performance. Second, methodologically, the variant-pathogenicity association is often assumed to comprise a linear component alongside a nonlinear one. However, current methods typically do not explicitly model the linear component, often failing to disentangle the linear component that might be better addressed with a linear approach.
resultsTo overcome these limitations, we introduce simultaneous modeling of linear and nonlinear components of knowledge graph (SIMLINK). This novel approach leverages a knowledge graph to model gene-variant-feature associations and a linear model to isolate the linear component. We begin by constructing a variant-centered knowledge graph, comprising over 8 million triplets, which explicitly models the associations between genes, variants, and features. Subsequently, the linear and nonlinear components are learned using a combination of linear and graph neural networks. We train SIMLINK on ClinVar variants. Benchmarking experiments on independent test sets demonstrate its superior prediction on both missense and synonymous variants compared to state-of-the-art methods, including CADD and AlphaMissense. We evaluate the impact of allele frequencies on prediction performance. Applied to variants implicated in Autism Spectrum Disorder, SIMLINK effectively distinguished between high- and low-confidence variants, and critically, the genes harboring top-ranked variants are highly pathogenic. AVAILABILITY AND IMPLEMENTATION: The source code is freely available at https://github.com/Chen-LuWang/SIMLINK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.